More metal improves Gianturco-Roubin FlexStent
This article was originally published in Clinica
US Company Cook has significantly improved the performance of its Gianturco-Roubin FlexStent by increasing the amount of metal in contact with the artery wall. The Gianturco-Roubin FlexStent II (GRII) has a metal-to-artery ratio of 18%, close to that for Cordis' Palmaz-Schatz and up from 11% with the first-generation stent. This has been achieved without sacrificing too much flexibility by using a flattened-wire for the coil.
You may also be interested in...
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.